Asya Grinberg

This inventor holds 1 USPTO granted patent. Top assignee: Acceleron Pharma Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Asya Grinberg. Retrieved from https://idiyas.com/inventor/asya-grinberg-m9vhliao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Asya Grinberg: Innovator in Pulmonary Disease Treatment

Introduction

Asya Grinberg is a notable inventor recognized for her contributions to the field of pulmonary disease treatment. With a focus on innovative methodologies, she has made significant strides in medical research.

Latest Patents

Asya Grinberg holds a patent titled "Methods for Treating Pulmonary Disease with a Ligand Binding Domain of a TGF-Beta Type II Receptor." This patent represents her commitment to advancing therapeutic options for patients suffering from pulmonary conditions. She has 1 patent to her name.

Career Highlights

Grinberg is currently associated with Acceleron Pharma Inc., a company dedicated to developing innovative therapies for serious diseases. Her work at Acceleron Pharma Inc. showcases her dedication to improving patient outcomes through scientific research.

Collaborations

Asya has collaborated with esteemed colleagues, including Paul B. Yu and Dianne S. Sako, who contribute to her research endeavors. Their combined expertise enhances the potential impact of her work in the medical field.

Conclusion

Asya Grinberg's innovative approach to treating pulmonary diseases highlights her role as a significant contributor to medical science. Her patent and collaborations reflect her commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…